Categories: News

Navigating Cancer Announces New Appointment to Board of Directors

SEATTLE, March 2, 2021 /PRNewswire-PRWeb/ — Navigating Cancer announced today that it has appointed Danielle Russella, President, Strategic Partnerships at Amwell, to its board of directors.

“We are pleased to welcome Danielle to Navigating Cancer’s board and especially value her point of view as a leader in digital health,” said Bill Bunker, Navigating Cancer’s CEO. “Danielle joins Navigating Cancer at an exciting time and will strengthen our ability to grow our digital health platform for oncology. Danielle complements our board of directors’ skills and experiences, and we are confident she will provide valuable perspectives as we continue to expand the patient services that can be delivered via our platform.”

Ms. Russella brings over 20 years of experience in healthcare leadership within the walls of technology companies serving the healthcare community. In her current role at Amwell, she provides thought-leadership to leading healthcare organizations implementing telemedicine and helps the company’s clients shape their telehealth strategies.

“I am extremely excited about the opportunity to contribute to Navigating Cancer’s mission and help advance its digital health platform to improve the lives of cancer patients,” says Danielle Russella. “Navigating Cancer’s remote care capabilities are at the forefront of cancer care innovation and are especially relevant in the context of current industry trends that have been accelerated by the COVID pandemic.”

About Navigating Cancer
Navigating Cancer is a digital health company focused on improving the lives of cancer patients and those who care for them. Our comprehensive Navigating Care® platform helps providers boost their financial performance, enables more effective remote care management, and delivers a better patient experience while providing valuable insights for oncology innovation. With over 2,500 providers using the Navigating Care platform to care for over 1 million patients, it is the most broadly deployed oncology patient management solution in the US. For more information, please visit http://www.navigatingcancer.com or follow Navigating Cancer on Twitter @navcancer.

Media Contact

Lena Shaw, Navigating Cancer, +1 949.813.2667, lshaw@navigatingcancer.com

 

SOURCE Navigating Cancer

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

10 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

10 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago